lobbying_activities: 2206802

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2206802	4e1ca9e2-e9a5-452f-aaa9-e12bef1ed9e0	Q3	ASSOCIATION OF NATIONAL ADVERTISERS, INC.	4653	ASSOCIATION OF NATIONAL ADVERTISERS, INC.	2018	third_quarter	PHA	Proposals relating to the regulation of direct-to-consumer prescription drug advertising H.R. 4385, Responsibility in Drug Advertising Act of 2017, which would prohibit DTC advertising of prescription drugs for the first three years after FDA approval Amendment to Labor-HHS appropriations bill and in omnibus appropriations bill (H.R. 6157) to require drug companies to list price information in direct-to-consumer prescription drug advertising	Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Natl Telecommunications & Information Administration (NTIA),SENATE,Treasury, Dept of		430000	0	0	2018-10-22T13:28:51.537000-04:00